Usana Health Sciences Inc risk profile
48 Elevated one input has moved against it
Measured 21 October 2026 from USNA's filed statements. Recomputed nightly.
48 (Elevated), driven by Market expectation at 66, over 4 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 66 | Stretched | Volatile | One-year price volatility — 54.9% |
| Operating pressure | Reads cost_of_revenue, operating_expense, operating_income and revenue. No reading is stored for this company. | |||
| Cash conversion | 39 | Normal | Stable | Capital spending against operating cash — 0.62x |
| Leverage and coverage | Reads total_debt, cash_and_cash_equivalents, ebitda, interest_expense, total_current_assets, total_current_liabilities and a disclosed CET1 ratio, for a bank or insurer. No reading is stored for this company. | |||
| Competitive position | 52 | Elevated | Stable | Revenue-growth gap against peers — -16.4 percentage points |
| Concentration | 40 | Elevated | Stable | Geographic concentration — 3,042 HHI |
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.
Consumer Defensive companies with a risk reading
Walmart Inc 51Costco Wholesale Corp 44Coca-Cola Company 39Procter & Gamble Company 30Philip Morris International Inc 24Nestle S.A. 46Nestlé S.A 47L'Oréal S.A. 38PepsiCo Inc 49Anheuser-Busch InBev SA/NV 36Unilever plc 45Unilever PLC 35
Financials, valuation and price history for Usana Health Sciences Inc